An observational, real world evidence study to describe clinical experience with lurasidone in the treatment of adult patients with schizophrenia in routine clinical
practice in Europe (LATUDA)

22/03/2019
14/03/2024
EU PAS number:
EUPAS28735
Study
Finalised
Documents
Study protocol
Initial protocol
English (885.02 KB - PDF) View document
Updated protocol
English (504.4 KB - PDF) View document
Study results
Study results
English (701.75 KB - PDF) View document
Study report
Other information
Study, other information
English (256.47 KB - PDF) View document